GAS5 protects against osteoporosis by targeting UPF1/SMAD7 axis in osteoblast differentiation

  1. Ming Li
  2. Zhongyu Xie
  3. Jinteng Li
  4. Jiajie Lin
  5. Guan Zheng
  6. Wenjie Liu
  7. Su'an Tang
  8. Shuizhong Cen
  9. Guiwen Ye
  10. Zhaofeng Li
  11. Wenhui Yu
  12. Peng Wang  Is a corresponding author
  13. Yanfeng Wu  Is a corresponding author
  14. Huiyong Shen  Is a corresponding author
  1. Sun Yat-sen Memorial Hospital, Sun Yat-sen University, China
  2. The Eighth Affiliated Hospital, Sun Yat-sen University, China
  3. Zhujiang Hospital, Southern Medical University, China

Abstract

Osteoporosis is a common systemic skeletal disorder resulting in bone fragility and increased fracture risk. It is still necessary to explore its detailed mechanisms and identify novel targets for the treatment of osteoporosis. Previously, we found that a lncRNA named GAS5 in human could negatively regulate the lipoblast/adipocyte differentiation. However, it is still unclear whether GAS5 affects osteoblast differentiation and whether GAS5 is associated with osteoporosis. Our current research found that GAS5 was decreased in the bones and BMSCs, a major origin of osteoblast, of osteoporosis patients. Mechanistically, GAS5 promotes the osteoblast differentiation by interacting with UPF1 to degrade SMAD7 mRNA. Moreover, a decreased bone mass and impaired bone repair ability were observed in Gas5 heterozygous mice, manifesting in osteoporosis. The systemic supplement of Gas5-overexpressing adenoviruses significantly ameliorated bone loss in an osteoporosis mouse model. In conclusion, GAS5 promotes osteoblast differentiation by targeting the UPF1/SMAD7 axis and protects against osteoporosis.

Data availability

The relevant data are available from Dryad (DOI: https://doi.org/10.5061/dryad.9cnp5hqfj). Primers of the analyzed genes (Supplementary Table 1), the siRNA sequences of the analyzed genes (Supplementary Table 2), characteristics of the study subjects (Supplementary Table 3) and Characteristics of the 15 healthy donors (Supplementary Table 4) can be found in the supplementary documents.

The following data sets were generated

Article and author information

Author details

  1. Ming Li

    Department of Orthopedics, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China
    Competing interests
    The authors declare that no competing interests exist.
  2. Zhongyu Xie

    Department of Orthopedics, The Eighth Affiliated Hospital, Sun Yat-sen University, Shenzhen, China
    Competing interests
    The authors declare that no competing interests exist.
  3. Jinteng Li

    Department of Orthopedics, The Eighth Affiliated Hospital, Sun Yat-sen University, Shenzhen, China
    Competing interests
    The authors declare that no competing interests exist.
  4. Jiajie Lin

    Department of Orthopedics, The Eighth Affiliated Hospital, Sun Yat-sen University, Shenzhen, China
    Competing interests
    The authors declare that no competing interests exist.
  5. Guan Zheng

    Department of Orthopedics, The Eighth Affiliated Hospital, Sun Yat-sen University, Shenzhen, China
    Competing interests
    The authors declare that no competing interests exist.
  6. Wenjie Liu

    Department of Orthopedics, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China
    Competing interests
    The authors declare that no competing interests exist.
  7. Su'an Tang

    Department of Orthopedics, Zhujiang Hospital, Southern Medical University, Guangzhou, China
    Competing interests
    The authors declare that no competing interests exist.
  8. Shuizhong Cen

    Department of Orthopedics, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China
    Competing interests
    The authors declare that no competing interests exist.
  9. Guiwen Ye

    Department of Orthopedics, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China
    Competing interests
    The authors declare that no competing interests exist.
  10. Zhaofeng Li

    Department of Orthopedics, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China
    Competing interests
    The authors declare that no competing interests exist.
  11. Wenhui Yu

    Department of Orthopedics, The Eighth Affiliated Hospital, Sun Yat-sen University, Shenzhen, China
    Competing interests
    The authors declare that no competing interests exist.
  12. Peng Wang

    Department of Orthopedics, The Eighth Affiliated Hospital, Sun Yat-sen University, Shenzhen, China
    For correspondence
    wangpengsmh@foxmail.com
    Competing interests
    The authors declare that no competing interests exist.
  13. Yanfeng Wu

    Center for Biotherapy, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China
    For correspondence
    wuyf@mail.sysu.edu.cn
    Competing interests
    The authors declare that no competing interests exist.
  14. Huiyong Shen

    Department of Orthopedics, The Eighth Affiliated Hospital, Sun Yat-sen University, Shenzhen, China
    For correspondence
    shenhuiy@mail.sysu.edu.cn
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-7104-3049

Funding

National Natural Science Foundation of China (81971518,81672097,81871750,81702120)

  • Zhongyu Xie
  • Peng Wang
  • Yanfeng Wu
  • Huiyong Shen

Ken Realm R&D Program of Guangdong Province (2019B020236001)

  • Huiyong Shen

Fundamental Research Funds for the Central Universities (19ykpy01)

  • Zhongyu Xie

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of Eighth Affiliated Hospital of Sun Yat-sen University. All procedures involving animals were approved by the Animal Use and Care Committee of the Eighth Affiliated Hospital of Sun Yat-sen University (approval number: SYSU-IACUC-2018-B10325).

Human subjects: The study was approved by the ethics committee of the Eighth Affiliated Hospital of Sun Yat-sen University (approval number: 2018r010) and it was performed in strict accordance with the recommendations of ethics committee. After explaining in detail the possible risks and importance of the research, as well as informing methods of privacy protection, we obtained the informed consent and consent publish signatures of all patients or normal donors.

Copyright

© 2020, Li et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,314
    views
  • 243
    downloads
  • 32
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Ming Li
  2. Zhongyu Xie
  3. Jinteng Li
  4. Jiajie Lin
  5. Guan Zheng
  6. Wenjie Liu
  7. Su'an Tang
  8. Shuizhong Cen
  9. Guiwen Ye
  10. Zhaofeng Li
  11. Wenhui Yu
  12. Peng Wang
  13. Yanfeng Wu
  14. Huiyong Shen
(2020)
GAS5 protects against osteoporosis by targeting UPF1/SMAD7 axis in osteoblast differentiation
eLife 9:e59079.
https://doi.org/10.7554/eLife.59079

Share this article

https://doi.org/10.7554/eLife.59079

Further reading

    1. Cell Biology
    Affiong Ika Oqua, Kin Chao ... Alejandra Tomas
    Research Article

    G protein-coupled receptors (GPCRs) are integral membrane proteins which closely interact with their plasma membrane lipid microenvironment. Cholesterol is a lipid enriched at the plasma membrane with pivotal roles in the control of membrane fluidity and maintenance of membrane microarchitecture, directly impacting on GPCR stability, dynamics, and function. Cholesterol extraction from pancreatic beta cells has previously been shown to disrupt the internalisation, clustering, and cAMP responses of the glucagon-like peptide-1 receptor (GLP-1R), a class B1 GPCR with key roles in the control of blood glucose levels via the potentiation of insulin secretion in beta cells and weight reduction via the modulation of brain appetite control centres. Here, we unveil the detrimental effect of a high cholesterol diet on GLP-1R-dependent glucoregulation in vivo, and the improvement in GLP-1R function that a reduction in cholesterol synthesis using simvastatin exerts in pancreatic islets. We next identify and map sites of cholesterol high occupancy and residence time on active vs inactive GLP-1Rs using coarse-grained molecular dynamics (cgMD) simulations, followed by a screen of key residues selected from these sites and detailed analyses of the effects of mutating one of these, Val229, to alanine on GLP-1R-cholesterol interactions, plasma membrane behaviours, clustering, trafficking and signalling in INS-1 832/3 rat pancreatic beta cells and primary mouse islets, unveiling an improved insulin secretion profile for the V229A mutant receptor. This study (1) highlights the role of cholesterol in regulating GLP-1R responses in vivo; (2) provides a detailed map of GLP-1R - cholesterol binding sites in model membranes; (3) validates their functional relevance in beta cells; and (4) highlights their potential as locations for the rational design of novel allosteric modulators with the capacity to fine-tune GLP-1R responses.